UBS Group
MD icon

UBS Group’s Pediatrix Medical MD Stock Holding History

UBS Group’s Portfolio MD Stock Details MD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-150,000
Closed -$6.49M – 8140
2018
Q2 		$6.49M Buy
150,000
+50,000
+50% +$2.4M ﹤0.01% 2116
2018
Q1 		$5.56M Buy
+100,000
New +$5.48M ﹤0.01% 2198

Other funds holding MD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

UBS Group's MD Position: Q1 2026 in Review

UBS Group reduced its Pediatrix Medical (MD) stake by 49% in Q1 2026, selling an estimated $6.02M and leaving 296,482 shares worth $6.34M. The position accounts for ﹤0.01% of the portfolio, ranked #3812.

UBS Group first reported a position in MD in Q4 2014 and has held it in 46 quarters since. The position peaked at $12.5M in Q4 2025. 296 funds tracked by Wall St. Rank hold MD as of Q1 2026.

  • UBS Group held 296,482 shares of Pediatrix Medical worth $6.34M as of Q1 2026.
  • UBS Group sold 289,268 Pediatrix Medical shares in Q1 2026, an estimated $6.02M.
  • Pediatrix Medical made up ﹤0.01% of UBS Group's portfolio in Q1 2026, its #3812 holding.
  • UBS Group first reported a position in Pediatrix Medical in Q4 2014 and has held it in 46 quarters since.
  • UBS Group's Pediatrix Medical position peaked at $12.5M in Q4 2025.
  • 296 funds tracked by Wall St. Rank held Pediatrix Medical as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.